Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)‐Hydroxynorketamine in Healthy Volunteers

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3391Source: DataRank Database

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)‐Hydroxynorketamine in Healthy Volunteers is a research paper published in Clinical Pharmacology & Therapeutics (2024). On theSindex it has a DataRank of 0. It has been cited 34 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access34 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 12.65)OA: hybridTopics (22)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (41)

Jeffrey T. Guptill ORCID,Michelle Mack,Marni Peterson,Stephen J. Byard,Robert J. Twieg ORCID

Live enrichment

PubMed:39054770 PMC:PMC11479831 OpenAlex:https://openalex.org/W4401037015

NIMH NIH HHS

Grant: R01 MH107615

Intramural NIH HHS

Grant: ZIA MH002857

BLRD VA

Grant: I01 BX004062

BLRD VA

Grant: I01 BX006018

Intramural NIH HHS

Grant: ZIA TR000042

Intramural NIH HHS

Grant: Z01 AG000297

FWCI

12.65

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3391

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3391

publisherhttps://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.3391

journalhttps://doi.org/10.1002/cpt.3391

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39054770

Fields of Study

Pharmacogenetics and Drug MetabolismNeuroscience and Neuropharmacology ResearchEicosanoids and Hypertension Pharmacology

MeSH Terms

AdolescentAdultAnesthetics, DissociativeAntidepressive AgentsDose-Response Relationship, DrugElectroencephalographyFemaleHumansKetamineMaleMiddle AgedYoung AdultHealthy Volunteers

Keywords

PharmacokineticsTolerabilityPharmacodynamicsPharmacologyMedicineAdverse effect

Sustainable Development Goals

SDG 0: Good health and well-being